-
April 16, 2013
The Alzheimer's Society in the UK has expressed disappointment over comments made by Sanofi chief executive Christopher Viehbacher who told Bloomberg the company will not be investing in the disease because of the difficulty in finding suitable targets
Full story
-
April 03, 2013
The cost effectiveness body has new powers to publish guidance and standards for the social care sector, and will also cost assess orphan medicines
Full story
-
February 08, 2013
The FDA has issued a proposal which it claims is designed to assist companies develop new treatments for early stages of Alzheimer’s disease, before the onset of noticeable dementia
Full story
-
February 05, 2013
The National Institute for Health and Clinical Excellence has put forward 32 new indicators to help support clinical commissioning groups (CCGs) make the best decisions for their patients.
Full story
-
January 08, 2013
NICE outlines plans for 14 new indicators for the 2014/15 GP Quality and Outcomes Framework, and unveils its new partner for supporting the development of guidelines for social care.
Full story
-
November 08, 2012
The government is shifting its approach to tackling dementia up a gear with a new package of measures including a massive call to action to the nation, £9.6 million in funding for research into the disease, and extra support for GPs.
Full story
-
October 18, 2012
The number of people suffering from depression in England has surged by nearly half a million in just three years.
Full story
-
August 02, 2012
A total 961.5 million prescription items were dispensed in the community in England last year, up 3.8% over 2010, but the total net ingredient cost of prescriptions dispensed was £8.8 billion, down 0.3% on the previous year, say new data.
Full story
-
July 05, 2012
An estimated 60% of the 800,000 patients living with dementia in the UK never receive a diagnosis, and there is huge variation in quality of services throughout the country, a report by MPs has revealed.
Full story
-
May 22, 2012
Hundreds of thousands of people with dementia in the UK are going under the radar as a lack of GP training in recognising the condition means they are not being diagnosed and treated.
Full story